Main finding: Improvement in visual and/or functional outcomes was achieved in more than 85% of participants who were treated with IAI monotherapy. The potential benefit of adding PDT could not be determined as fewer than 15% met the criteria of a suboptimal response to receive PDT.
Purpose: To evaluate intravitreal aflibercept injection (IAI) in PCV and compare IAI monotherapy with IAI plus rescue photodynamic therapy (PDT)
Source Archive